The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

On August 5, 2013, a marketing authorization valid throughout the European Union (EU) was issued for pomalidomide in combination with dexamethasone for the treatment of adult patients with relapsed and refractory multiple myeloma (MM) who have received at least two prior treatment regimens, includin...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Hanaizi, Zahra, Flores, Beatriz, Hemmings, Robert, Camarero, Jorge, Sancho-Lopez, Arantxa, Salmonson, Tomas, Gisselbrecht, Christian, Laane, Edward, Pignatti, Francesco
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2015
Subjects:
Regulatory Issues: EMA
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350811/
https://ncbi.nlm.nih.gov/pubmed/25673103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0073
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items